Treating and Defeating Hepatitis C in RI

RI Defeats Hep C

May 6, 2014
Th eOmni Providence Hotel
1 West Exchange Street, Providence, RI 02903

Program Description
At no other time in history has hepatitis C virus infection (HCV) been such an urgent problem. The ‘tidal wave’ of the epidemic has hit: ‘Baby Boomers’ infected years ago are now falling ill due to HCV-induced end-stage liver disease and liver cancer, and face tremendous suffering, inability to work and premature death. Only large-scale improvements in HCV care delivery, concomitant with the revolution occurring in HCV treatment, will avert decades of preventable morbidity and mortality. The standard of care for HCV therapy is rapidly evolving with the advent of direct-acting antiviral agents (DAAs). This program provides an overview of current and future HCV screening, care and treatment; addresses emerging issues facing practitioners and public health organizations; and presents HCV epidemiology and strategies to expand capacity to cure.

Target Audience
Physicians, nurse practitioners, nurses, physician assistants, pharmacists, psychologists, social workers, and other health care practitioners involved in the diagnosis and management of patients with HCV infection as well as practitioners in: gastroenterology, hepatology, infectious diseases, HIV, corrections, internal medicine, family medicine, psychiatry & public health.

Learning Objectives
At the conclusion of this educational activity, participants should be able to:

  1. Recognize new groups at risk so as to identify undiagnosed HCV infection
  2. Apply HCV screening and treatment guidelines to a clinic population
  3. Recognize the benefits of achieving HCV cure and the importance of optimizing adherence to achieve cure
  4. Describe strategies for treating patients infected with genotypes 1, 2 and 3
  5. Define the role of interferon-sparing, all-oral HCV regimens
  6. Appraise emerging data on investigational HCV agents and how they will likely affect current practice, and be prepared to use novel direct-acting antiviral agents as they become available
  7. Discuss the public health implications of HCV epidemiology and costs of care

Register online at:
https://apps.biomed.brown.edu/cme_registration

Conference registration fee includes:  Continental breakfast, breaks, lunch, access to an online syllabus, and complimentary on-site parking.

$100.00 MD/DO
$75.00 Pharmacists
$50.00 Other Healthcare Professionals, Students, Residents, Fellows

CME Accreditation
The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME/CE Credit Designations
Physicians: The Warren Alpert Medical School of Brown University designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits(TM). Physicians should claim on the credit commensurate with the extent of their participation in the activity.

Psychologists: The Warren Alpert Medical School is approved by the RI Psychological Association to offer continuing education credits for Psychologists. The Alpert Medical School maintains responsibility for the program. This program is approved for 7.0 Category 1 CE Credits. Credits available to RI licensed psychologists only.

Social Workers: An application has been submitted to the NASW Rhode Island Chapter for this activity. CE Approval is pending.

Nursing Credit: An application has been submitted to the New England AIDS Education and Training Center and the Board of Registration in Nursing of the Commonwealth of Massachusetts. CE Approval is pending.

Continuing Pharmacy Education Information
The University of Rhode Island, College of Pharmacy, is accredited by the
Accreditation Council for Pharmacy Education as a provider of continuing
pharmacy education. Attendance and completion of online evaluations and
self-assessment tools at the conclusion of the program are required for issuance of a statement of credit.

UNIVERSAL ACTIVITY NUMBERS: This learning activity provides 7 contact hours (0.7 CEUs) of continuing pharmacy education credit. UAN 0060-9999-14-053-L01-P. This is a knowledge based learning activity.

Financial support for this program has been provided by the New England AIDS Education and Training Center project, funded by the U.S. Department of HHS, Health Resources and Services Administration, and sponsored regionally by Commonwealth Medicine, UMass Medical School, Worcester, MA.